NuVasive Inc. (NSDQ:NUVA) can review documents covering Lanx Inc.‘s contacts with current and former NUVA employees it alleges were poached by Lanx.
Nuvasive
NuVasive’s global sales president is on the way out | Personnel Moves
NuVasive takes a shellacking on lowered guidance | Wall Street Beat
NuVasive Inc. (NSDQ:NUVA) shares are down more than 30% today after the medical device company said yesterday that its 3rd-quarter results are likely to be substantially lower than predicted.
San Diego-based NuVasive, which makes spinal surgery implants, said 3rd-quarter sales will be about $147 million, 4.8% below the roughly $154.4 million the company expected to post.
Analysts differ on Abbott’s post-split prospects | Wall Street Beat
Wall Street analysts are by and large predicting good things for Abbott (NYSE:ABT) after it spins out its branded pharmaceuticals division, to be named AbbVie, early next year.
But, although some are decidedly bullish on ABT, others are taking a more cautious approach until more is known about the structure of the deal.
Appeals court reverses $60M NuVasive trademark loss
NuVasive Inc. (NSDQ:NUVA) won a big legal victory yesterday when a federal appeals court reversed a lower court’s $60 million decision in favor of NeuroVision Medical Products, rebuking the lower court judge in the process.
The decision means the case pitting the medical device companies against each other will be re-tried under a different district court judge.
NuVasive vows to fight Medtronic’s latest patent blitz
NuVasive Inc. (NSDQ:NUVA) is prepared to go another round in the long-running spinal patent battle against Medtronic (NYSE:MDT).
Medtronic sues NuVasive – again
Medtronic (NYSE:MDT) is taking its long-running patent beef with NuVasive Inc. (NSDQ:NUVA) to Indiana with a new lawsuit claiming infringement of spinal implant patents.
Legal News: Covidien’s Nellcor subsidiary sues CasMed
MassDevice.com +3 | The top 3 med-tech stories for July 30, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Legal news: NuVasive goes after ex-sales reps now with Lanx
NuVasive Inc. (NSDQ:NUVA) opened another front in its ongoing war with rival Lanx Inc., accusing 3 former sales reps of defecting to Lanx and taking trade secrets with them.
Spine: Wall Street wavers on NuVasive’s latest quarter as charges outpace sales growth
Wall Street wavered on spine surgery devices maker NuVasive Inc. (NSDQ:NUVA) today after the company released its latest earning report.
For the 3 months ended June 30 NuVasive reported $154.4 million in sales, a 16.1% spike from the $133 million reporting for the same period last year.